Australia markets closed

Ikena Oncology, Inc. (IKNA)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
1.6500-0.1000 (-5.71%)
At close: 04:00PM EDT
1.6600 +0.01 (+0.61%)
After hours: 05:47PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-51,871
-68,166
-68,765
-34,115
-44,256
Depreciation & amortisation
704
1,020
751
544
300
Stock-based compensation
7,247
7,632
7,525
5,177
1,797
Change in working capital
-27,449
-21,669
-15,138
-33,032
-7,771
Accounts receivable
249
-2,870
-291
361
519
Other working capital
-71,572
-80,157
-75,540
-62,012
-38,592
Other non-cash items
1,259
1,714
1,283
1,174
12,104
Net cash provided by operating activities
-69,822
-79,743
-74,109
-60,252
-37,826
Cash flows from investing activities
Investments in property, plant and equipment
-1,750
-414
-1,431
-1,760
-766
Purchases of investments
-110,624
-90,052
-216,338
0
-
Sales/maturities of investments
137,038
154,610
118,485
0
-
Net cash used for investing activities
-110,333
64,144
-99,284
-1,760
2,922
Cash flows from financing activities
Common stock issued
0
37,421
0
131,302
-
Common stock repurchased
-
-663
0
-146
-57
Other financing activities
-
-944
-
-
-57
Net cash used provided by (used for) financing activities
1,330
75,980
1,095
131,738
116,184
Net change in cash
-178,825
60,381
-172,298
69,726
81,280
Cash at beginning of period
246,771
60,791
233,089
163,363
82,083
Cash at end of period
67,946
121,172
60,791
233,089
163,363
Free cash flow
Operating cash flow
-69,822
-79,743
-74,109
-60,252
-37,826
Capital expenditure
-1,750
-414
-1,431
-1,760
-766
Free cash flow
-71,572
-80,157
-75,540
-62,012
-38,592